Trending in Immunology: Ultomiris Priority Review, Cosentyx PMR Data & more

This edition highlights important developments across immunology, including positive Phase 3 data for Cosentyx in polymyalgia rheumatica, interim kidney-function results for VOYXACT in IgA nephropathy, and new Phase 2 findings for nipocalimab in systemic lupus erythematosus and Sjögren’s disease. Regulatory activity includes FDA Priority Review for Ultomiris in IgA nephropathy and Tecentriq in stage III dMMR/MSI-H colon cancer, alongside progress for pediatric ENTYVIO and expanded EBGLYSS maintenance dosing options.

Видео Trending in Immunology: Ultomiris Priority Review, Cosentyx PMR Data & more канала LucidQuest